← Eichor
Study identifier: NCT07711106 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

"Expert IVUS-Eye" vs. IVUS-guided Left Main Bifurcation PCI

Condition: Coronary Artery Disease (CAD) · Chronic Coronary Syndrome · Left Main Coronary Artery Disease  ·  Sponsor: Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health

PhaseNA
Planned participants50
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

This is a prospective, randomized, controlled trial comparing two strategies for optimizing stent implantation during bifurcation stenting of the left main coronary artery (LM): an intravascular ultrasound (IVUS)-guided approach versus a "IVUS-trained eye" approach based on angiographic assessment and operator experience. All patients receive the same stent brand and procedure steps to minimize variability. The primary objective is to compare the planimetric stent appearance between two strategies.

This description comes directly from the study's public registry record.

Talk to the study team

Aleksei A. Prokhorikhin, PhD  ·  +79137178040  ·  aa.prohorihin@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of HealthSaint Petersburg, RussiaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07711106